Through the RTI, we ensure that our research is:
- Efficiently progressed through clinical studies to generate the high quality data required – through the operational expertise and dedicated space provided by our Biomarker Platforms and the NIHR Manchester Clinical Research Facility. The efficiency of our clinical study delivery is also supported by NorthWest EHealth – its FARSITE database enables researchers to perform complex searches of electronic records to understand study recruitment feasibility
- Accessible and inclusive to encourage recruitment and retention of local people into clinical research studies through optimal study design, involving input from patients by working with the North West Hub for Trials Methodology Research, Trials@Manchester, the NIHR Research Design Service North West, and patients and members of the public. We will also broker opportunities for BRC researchers and local people to participate in NIHR Translational Research Collaborations and Partnership (TRC) initiatives. Our work with the CRF and NIHR Clinical Research Network, which supports the delivery of later phase clinical studies resulting from BRC research, also provides an opportunity to make our studies available at other sites across the country
- Supported through further external investment to maximise the potential for our research to have an impact on people’s health
- Rapidly adopted into routine clinical practice across Greater Manchester and beyond. This will involve working with UMIP (The University of Manchester) and TRUSTECH (the NHS) – to protect and, where appropriate, commercialise intellectual property generated by the BRC. The adoption and dissemination of our research outputs will also be supported through our relationships with the North Health Science Alliance and Academic Health Science Network
Learn more about the diverse range of knowledge and expertise we will be leveraging to achieve the BRC’s ambitious goals.